Researchers develop nanoparticles delivering STING agonists for intravenous cancer immunotherapy – News-Medical.net

Cancer immunotherapy seeks to turn “cold” tumors into “hot” tumors––those that respond to immunotherapy––by awakening and enlisting the body’s own immune system.
Unfortunately, few people benefit from the most common form of immunotherapy, called immune…

Click here to view the original article.